Tumor suppressor gene

Details Tumor suppressor gene Tumor suppressor gene

2009-11-25

2010-11-02

Yu, Misook (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C435S069700, C435S007100, C435S326000, C530S388150

Reexamination Certificate

active

07825220

ABSTRACT:
A full-length cDNA encoding novel proteins involved in the control of cell proliferation (human Gros1-L and S) was successfully isolated from the human testis cDNA libraries. A full-length cDNA encoding the mouse homologues of the human Gros1 (mouse Gros1-L and S) was also isolated. The colony forming activity of cells exogenously expressing Gros1-L was significantly reduced, while that of cells expressing Gros1 antisense RNA was significantly increased.

REFERENCES:
patent: 6783961 (2004-08-01), Edwards et al.
patent: WO 89/04875 (1989-06-01), None
Wassenhove-McCarthy et al., “Molecular Characterization of a Novel Basement Membrane-associated Proteoglycan, Leprecan”, J. Biol. Chem.., 274:25004-25017, 1999.
Aravind et al., “The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases,” Genome Biol., 2:1-6 (2001).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,” Science, 247:1306-10 (1990).
Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue,” J. Cell Biol., 111:2129-38 (1990).
Couchman et al., “Perlecan and Basement Membrane-Chondroitin Sulfate Proteoglycan (Bamacan) are Two Basement Membrane Chondroitin/Dermatan Sulfate Proteoglycans in the Englebreth-Holm-Swarm Tumor Matrix,” J. Biol. Chem., 271:9595-9602 (1996).
Daigo et al., “Molecular Cloning of a Candidate Tumor Suppressor Gene,DLC1, from Chromosome 3p21.3,” Cancer Res., 59:1966-72 (1991).
EMBL Accession No. AA887980 (Apr. 2, 1998).
Geck et al., “Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rbl locus,” J. Steroid Biochem. Mol. Biol., 68:41-50 (1999).
Kaul et al., “Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecan,” Oncogene, 19:3576-83 (2000).
Lazar et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities,” Mol. Cell. Biol., 8:1247-52 (1988).
Nigro et al., “The human ROX gene: Genomic structure and mutation analysis in human breast tumors,” Genomics, 49:275-282 (1998).
Definition of “Polypeptide” in Merriam-Webster Online Dictionary (downloaded from url>>www.m-w.com on Aug. 21, 2004).
Roussel et al., “Inhibition of Cell Proliferation by the Mad1 Transcriptional Repressor,” Mol. Cell. Biol., 16:2796-2801 (1996).
Wassenhove-McCarthy et al., “Molecular Characterization of a Novel Basement Membrane-associated Proteoglycan, Leprecan,” J. Biol. Chem., 274:25004-17 (1999).
USPTO Non-Final Office Action in U.S. Appl. No. 10/045,815, mailed Aug. 24, 2004, 17 pages.
Fish & Richardson P.C., Amendment in Reply to Action dated Aug. 24, 2004 in U.S. Appl. No. 10/045,815, filed Dec. 23, 2004, 9 pages.
USPTO Final Office Action in U.S. Appl. No. 10/045,815, mailed Apr. 20, 2005, 9 pages.
Fish & Richardson, P.C., Amendment in Reply to Action dated Apr. 20, 2005 in U.S. Appl. No. 10/045,815, filed Oct. 17, 2005, 7 pages.
Fish & Richardson, P.C., Amendment in Reply to Action dated Apr. 20, 2005 in U.S. Appl. No. 10/045,815, filed May 16, 2006, 8 pages.
USPTO Non-Final Office Action in U.S. Appl. No. 11/603,619, mailed Aug. 11, 2008, 11 pages.
Fish & Richardson P.C., Amendment in Reply to Action dated Aug. 11, 2008 in U.S. Appl. No. 11/603,619, filed Nov. 12, 2008, 11 pages.
USPTO Final Office Action in U.S. Appl. No. 11/603,619, mailed Feb. 2, 2009, 9 pages.
Fish & Richardson, P.C., Amendment in Reply to Action dated Feb. 2, 2009 in U.S. Appl. No. 11/603,619, filed Jun. 2, 2009, 8 pages.
Supplemental Partial European Search Report issued in European Application No. EP00922881 on Jun. 2002 (4 pages).
International Search Report issued in PCT/JP00/02731 on Aug. 2000 (1 page).

Affiliated with

Also associated with

Rating

Tumor suppressor gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor suppressor gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor suppressor gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4204873